1. Home
  2. YAAS vs CRIS Comparison

YAAS vs CRIS Comparison

Compare YAAS & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Youxin Technology Ltd

YAAS

Youxin Technology Ltd

HOLD

Current Price

$1.31

Market Cap

20.9M

Sector

Technology

ML Signal

HOLD

Logo Curis Inc.

CRIS

Curis Inc.

HOLD

Current Price

$0.87

Market Cap

2.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YAAS
CRIS
Founded
2018
2000
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.9M
2.3M
IPO Year
2023
2000

Fundamental Metrics

Financial Performance
Metric
YAAS
CRIS
Price
$1.31
$0.87
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $17.00
AVG Volume (30 Days)
★ 190.0K
132.7K
Earning Date
01-29-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 91.57
EPS
★ N/A
N/A
Revenue
N/A
★ $9,898,000.00
Revenue This Year
N/A
$27.10
Revenue Next Year
N/A
$67.74
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 31.50
52 Week Low
$0.56
$0.18
52 Week High
$4.98
$6.74

Technical Indicators

Market Signals
Indicator
YAAS
CRIS
Relative Strength Index (RSI) 34.50 18.87
Support Level $1.24 $0.80
Resistance Level $1.88 $1.04
Average True Range (ATR) 0.09 0.11
MACD -0.01 0.04
Stochastic Oscillator 31.73 6.59

Price Performance

Historical Comparison
YAAS
CRIS

About YAAS Youxin Technology Ltd

Youxin Technology Ltd is a SaaS and PaaS provider committed to helping retail enterprises digitally transform their businesses to develop, use and control business applications without the need to purchase complex IT infrastructure. The company leverages the technologies used to develop its PaaS platform to standardize customized customer relationship management, or CRM, services to its clients that seamlessly connect all levels of the retail chain from management teams to customers. Its products give its retail clients a comprehensive view of their business operations in real-time on multiple interfaces, allowing them to make critical business decisions anytime and anywhere. Geographically operates in PRC, Hong Kong, and Cayman Island.

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Share on Social Networks: